Zeposia Unia Europejska - polski - EMA (European Medicines Agency)

zeposia

bristol-myers squibb pharma eeig - ozanimod chlorowodorek - multiple sclerosis, relapsing-remitting; colitis, ulcerative - leki immunosupresyjne - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Dimethyl fumarate Mylan Unia Europejska - polski - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - fumaran dimetylu - stwardnienie rozsiane, Рецидивно-znika - leki immunosupresyjne - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Unia Europejska - polski - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - fumaran dimetylu - stwardnienie rozsiane, Рецидивно-znika - leki immunosupresyjne - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Unia Europejska - polski - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - fumaran dimetylu - stwardnienie rozsiane, Рецидивно-znika - leki immunosupresyjne - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Spevigo Unia Europejska - polski - EMA (European Medicines Agency)

spevigo

boehringer ingelheim international gmbh - spesolimab - Łuszczyca - leki immunosupresyjne - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.

Dimethyl fumarate Teva Unia Europejska - polski - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - fumaran dimetylu - multiple sclerosis, relapsing-remitting; multiple sclerosis - leki immunosupresyjne - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Unia Europejska - polski - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - fumaran dimetylu - multiple sclerosis, relapsing-remitting; multiple sclerosis - leki immunosupresyjne - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).